Cox Proportional Hazards model
This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Cox Proportional Hazards model | |
|---|---|
 | |
| Name | Cox Proportional Hazards model |
| Type | Survival analysis |
| Introduced | 1972 |
| Author | Sir David Cox |
| Fields | Statistics, Biostatistics, Epidemiology |
Cox Proportional Hazards model The Cox Proportional Hazards model is a semiparametric regression model widely used in Statistics and Biostatistics for time-to-event data. Developed by Sir David Cox in 1972, the model connects covariates to hazard rates without specifying a baseline hazard, enabling applied work in Epidemiology, Clinical trials, and Reliability engineering. Its adoption spans research at institutions like Harvard University, University of Oxford, and agencies such as the World Health Organization and the Centers for Disease Control and Prevention.
Introduction
The Cox model relates the hazard function to covariates through a multiplicative structure linking observed predictors from studies at Johns Hopkins University, Mayo Clinic, and Imperial College London to outcomes. Early use occurred in cohorts studied by investigators at National Institutes of Health and in randomized trials run by groups like Food and Drug Administration collaborators. Prominent textbooks by authors affiliated with Columbia University, Stanford University, and University of Cambridge helped disseminate the method internationally, influencing practice in settings from World Bank-funded health surveys to trials at Massachusetts General Hospital.
Mathematical formulation
Let T denote a nonnegative random time with hazard h(t | X). The Cox model posits h(t | X) = h0(t) exp(β'X), where h0(t) is an unspecified baseline hazard and β are regression coefficients estimated from data collected in cohorts like those at Fred Hutchinson Cancer Research Center or trials run by National Cancer Institute. The partial likelihood, score functions, and information matrices link to classical results from Andrey Kolmogorov-inspired probability and methods used by researchers at Princeton University, Yale University, and University of California, Berkeley.
Estimation and inference
Estimation typically proceeds by maximizing the partial likelihood introduced by Sir David Cox, leveraging asymptotic theory developed in part at Bell Labs and formalized in academic departments such as University of Chicago and London School of Economics. Variance estimates use robust sandwich estimators familiar to analysts at Kaiser Permanente, Pfizer, and regulatory statisticians at European Medicines Agency. Hypothesis tests often mirror likelihood ratio, score, and Wald tests used in works from Royal Statistical Society conferences and applied in multi-center trials coordinated by World Health Organization collaborating centers.
Extensions and variations
Extensions include stratified Cox models used in multi-center studies led by Johns Hopkins University investigators, time-dependent covariates applied in longitudinal studies at University College London, and frailty models incorporating random effects inspired by work at Institut Pasteur and Max Planck Society. Additive hazards, accelerated failure time models, and cure models have been developed alongside contributions from scholars at Princeton University, University of Oxford, and Harvard School of Public Health, while high-dimensional regularized Cox variants draw on algorithms from AT&T Bell Laboratories and machine-learning groups at Google and Microsoft Research.
Model assessment and diagnostics
Diagnostic tools include Schoenfeld residuals, Martingale residuals, and time-dependent ROC curves used in evaluations by teams at Mayo Clinic and Stanford Medical School. Goodness-of-fit and proportionality tests have been discussed in methodological work presented at conferences organized by American Statistical Association and Royal Statistical Society, and applied in guideline development at World Health Organization and regulatory reviews by Food and Drug Administration. Graphical checks and influence measures are standard in applied reports from centers like Dana-Farber Cancer Institute.
Applications and examples
The Cox model has been applied to oncology trials at National Cancer Institute, cardiovascular cohorts from Framingham Heart Study, and public health analyses by Centers for Disease Control and Prevention and World Health Organization. Examples include survival analyses in studies conducted at Mayo Clinic, organ transplant registries maintained by United Network for Organ Sharing, and epidemiologic cohorts from Nuffield Department of Population Health. It is used in industrial reliability studies at firms like General Electric and in actuarial research at Prudential Financial.
Software implementations
Implementations are available in major statistical packages: R (programming language) packages such as survival are widely used, commercial software like SAS (software) PROC PHREG and Stata (software)'s stcox are standard in regulated trials submitted to Food and Drug Administration and European Medicines Agency. Python libraries developed by contributors linked to NumPy and SciPy communities provide Cox functionality, while platforms from IBM and MathWorks integrate survival modeling into enterprise workflows.
Category:Statistical models